
 |
|
May 16, 2012
Carmen Terzic, M.D., Ph.D. : Mayo Clinic Medical Edge: A variety of exercises can help improve balance
Melissa Healy: National strategy on Alzheimer's disease aims to halt it by 2025
The Kosher Gourmet by Joyce White : GOODNESS GRACIOUS: GREENS! 4 winning recipes that are no longer just for down-home folks (Includes expert tips & techniques)
May 15, 2012
Kristen Chick: Obama administration resumes arms sales to Bahrain despite serious unresolved human rights issues. Activists feel abandoned
Pat Mertz Esswein: Homes are now affordable again and mortgage rates are low. What you need to know before you buy
Kathy Kristof: Our Practical Investor Fights Inflation with These 6 Investments
Sue Hubbard, M.D.: The Kid's Doctor: Lactose intolerant young child? Check again
The Kosher Gourmet by Kathy Hunt: Spread a Little Excitement with EXOTIC CONDIMENTS (4 RECIPES)
May 14, 2012
Lisa Gerstner: How to Protect Your Identity, Finances If You Lose Your Phone
Harvard Health Letters: Heart disease and dementia
The Kosher Gourmet by Megan Gordon: MANGO COCONUT OAT MORNING MUFFINS are a bright but hearty delight
May 11, 2012
Jessica L. Anderson: Get the Best Deal on a Used Car
Jett Stone: Forget face-lifts and fake knees. Scientists have seen the fountain of youth --- and it's broccoli
The Kosher Gourmet by Chef Mario Batali: The famed chef's vegetable dish that tastes true to the season: FAVAS AND SUGAR SNAP PEAS WITH POTATOES AND TARRAGON
May 10, 2012
Sergei L. Loiko: Putin sends warning to U.S., NATO in Victory Day speech at Red Square
Mary Rourke: How being a 'mentch' got Vidal Sasoon his start and fighting in Israel's War of Independence provided him with confidence and a strong sense of his own identity
Jeff Bertolucci: Get Home Phone Service for Less Than $10 a Month
The Kosher Gourmet by Betty Rosbottom: Gleaming with its golden, crimson, and snowy white hues, this silken smooth and creamy STRAWBERRY ORANGE TRIFLE looks impressive, but is easy to prepare
May 9, 2012
Sharon Palmer, R.D. How you can reduce your risk -- or delay -- chronic diseases associated with aging
|
| |
Jewish World Review
Jan. 16, 2007
/ 26 Teves, 5767
The Big Drug scam
By
Rich Lowry
| 
|
|
|
|
http://www.JewishWorldReview.com |
Democrats hate that Republicans are willing, on the issue of embryonic stem-cell research, to let their straitened moral views supposedly stand in the way of medical progress. But Democrats have their own ethical problem with medical progress based on their moral qualms about the profit motive.
During the 2006 campaign, Democrats argued that President Bush's prescription-drug program Medicare Part D could never be cost-effective unless the government was allowed to negotiate directly with drug companies. According to the Democrats, the "D" in Medicare "Part D" stood for "dystopia," forcing dazed and confused seniors to be ripped off by ravenous drug companies.
They never bothered to notice that Medicare Part D has been an unexpected success. Perhaps not since JFK's campaign against a nonexistent "missile gap" in the 1960 presidential campaign has winning election-year rhetoric been so bogus.
The absence of government negotiations has been key to the program's success. Private health plans negotiate drug prices with the drug companies and then offer a menu a formulary of covered drugs through Medicare. Seniors choose among the various plans, picking the one with the drugs they want at the best price.
According to the Centers for Medicare and Medicaid Services, the robust competition has meant that premiums for the basic drug benefit average $22 per month, 40 percent less than had been projected. Seniors are estimated to be saving, on average, $1,200 a year on drugs, and 80 percent of seniors enrolled in the program are satisfied with it.
Ahh, but somewhere, someone might be making a profit! Democratic Rep. Jan Schakowsky (D-Ill.) recently noted that drug companies reaped $8 billion in increased profits in the first six months of Medicare Part D, so "it's time to protect the interests of the American people." Never mind that one factor in the profits, according even to an analysis by liberal lion Rep. Henry Waxman, is "higher sales volumes of drugs. Many seniors who previously did not have drug coverage now do."
As it happens, government negotiations of prices won't do any good unless the government is empowered not to offer certain drugs, thus achieving real bargaining power. This would require creating a national formulary in other words limiting the drugs available to seniors in the Medicare program.
The United States Department of Veterans Affairs touted by Democrats as an ideal example of government negotiations has just such a formulary. If the latest drug isn't on the VA list well, there are always old drugs. Columbia University professor Frank Lichtenberg reports that "only 38 percent of drugs approved in the 1990s and 19 percent of the drugs approved by the FDA since 2000 are on the VA National Formulary." Robert Goldberg of the Center for Medicine in the Public Interest points out that Azilect, the latest drug to treat Parkinson's disease, is covered by every private Medicare Part D plan, but not by the VA.
Democrats don't want to impose a formulary on Medicare Part D because they know that it will cause a revolt. So their negotiation scheme, passed by the House last week, has no chance of lowering prices. At least Democrats will have struck a symbolic blow against profits.
They used to complain that drug companies made too many "me-too drugs," but the variety of drugs available to treat the same conditions has created healthy competition regarding price. Now Democrats complain about one-of-a-kind breakthrough drugs, where there isn't (yet) such competition.
But drug research is risky and hideously expensive. No one will do it without the benefit of profits. One of the companies that Waxman excoriated for making profits in his analysis last September was Pfizer. Too bad he didn't wait until December, when Pfizer's new cholesterol-lowering drug proved a failure, meaning it had lost 15 years and $1 billion in research and development costs. Now Waxman could attack the company for planning to lay off workers.
If they continue crusading against drug-industry profits, Democrats will succeed only in obstructing medical progress, to the detriment of seniors and all of us.
Every weekday JewishWorldReview.com publishes what many in in the media and Washington consider "must-reading". Sign up for the daily JWR update. It's free. Just click here.
Comment by clicking here.
Rich Lowry Archives
© 2006 King Features Syndicate
|
|

Arnold Ahlert
Mitch Albom
Jay Ambrose
Michael Barone
Barrywood
Lori Borgman
Stratfor Briefing
Mona Charen
Linda Chavez
Richard Z. Chesnoff
Ann Coulter
Greg Crosby
Alan Douglas
Larry Elder
Suzanne Fields
Frank J. Gaffney
Bernie Goldberg
Jonah Goldberg
Julia Gorin
Jonathan Gurwitz
Paul Greenberg
Argus Hamilton
Victor Davis Hanson
Betsy Hart
Ron Hart
Nat Hentoff
Marybeth Hicks
A. Barton Hinkle
David Horowitz
Jeff Jacoby
Renee James
Paul Johnson
Jack Kelly
Ed Koch
Ch. Krauthammer
Michael Ledeen
John Leo
David Limbaugh
Kathryn Lopez
Rich Lowry
Michelle Malkin
Jackie Mason
Ann McFeatters
Dale McFeatters
Dana Milbank
Jeanne Moos
Dick Morris
Jim Mullen
Deroy Murdock
Judge A. Napolitano
Bill O'Reilly
Kathleen Parker
Star Parker
Dennis Prager
Wesley Pruden
Tom Purcell
Sharon Randall
Robert Robb
Cokie & Steve Roberts
Heather Robinson
Pat Sajak
Debra J. Saunders
Martin Schram
Culture Shlock
David Shribman
Roger Simon
Michael Smerconish
Thomas Sowell
Ben Stein
Mark Steyn
John Stossel
Cal Thomas
Dan Thomasson
Bob Tyrrell
Ben Wattenberg
Diana West
Dave Weinbaum
George Will
Walter Williams
Byron York
ZeitGeist
Mort Zuckerman

Robert Arial
Chuck Asay
Baloo
Chip Bok
Dry Bones
Lisa Benson
John Branch
John Cole
J. D. Crowe
John Deering
Brian Duffy
Everything's Relative
Mallard Fillmore
Glenn Foden
Jake Fuller
Bob Gorrel
Walt Handelsman
Joe Heller
David Hitch
Jerry Holbert
David Horsey
Lee Judge
Steve Kelley
Jeff Koterba
Dick Locher
Chan Lowe
Jimmy Margulies
Jack Ohman
Michael Ramirez
Drew Sheneman
Kevin Siers
Jeff Stahler
Scott Stantis
Ed Stein
Danna Summers
John Trever
Gary Varvel
Kirk Walters
Dan Wasserman

Mr. Know-It-All
Ask Doctor K
Richard Lederer
Frugal Living
Tech Maven
On Nutrition
Bookmark These
Bruce Williams
|